JP2004529091A - 免疫療法剤と共に使用するためのペリレンキノン - Google Patents

免疫療法剤と共に使用するためのペリレンキノン Download PDF

Info

Publication number
JP2004529091A
JP2004529091A JP2002560673A JP2002560673A JP2004529091A JP 2004529091 A JP2004529091 A JP 2004529091A JP 2002560673 A JP2002560673 A JP 2002560673A JP 2002560673 A JP2002560673 A JP 2002560673A JP 2004529091 A JP2004529091 A JP 2004529091A
Authority
JP
Japan
Prior art keywords
hypocrellin
tumor
cells
group
pdt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002560673A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004529091A5 (https=
Inventor
ベアトリス・ルヴェーグル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2004529091A publication Critical patent/JP2004529091A/ja
Publication of JP2004529091A5 publication Critical patent/JP2004529091A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2002560673A 2001-01-30 2002-01-29 免疫療法剤と共に使用するためのペリレンキノン Pending JP2004529091A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26467701P 2001-01-30 2001-01-30
PCT/IB2002/000267 WO2002060482A2 (en) 2001-01-30 2002-01-29 Perylenequinones for use with immunotherapy agents

Publications (2)

Publication Number Publication Date
JP2004529091A true JP2004529091A (ja) 2004-09-24
JP2004529091A5 JP2004529091A5 (https=) 2005-12-22

Family

ID=23007123

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002560673A Pending JP2004529091A (ja) 2001-01-30 2002-01-29 免疫療法剤と共に使用するためのペリレンキノン

Country Status (9)

Country Link
US (1) US20040110846A1 (https=)
EP (1) EP1357944B1 (https=)
JP (1) JP2004529091A (https=)
CN (1) CN1665535A (https=)
AT (1) ATE364398T1 (https=)
AU (1) AU2002234809B2 (https=)
CA (1) CA2436233C (https=)
DE (1) DE60220642T2 (https=)
WO (1) WO2002060482A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1349965A (zh) * 2000-10-25 2002-05-22 中国科学院感光化学研究所 带有脂肪环或芳香环的脂肪胺基取代去甲氧基竹红菌素及其合成方法和用途
US6627664B2 (en) * 2001-01-30 2003-09-30 Altachem Pharma Ltd. Perylenequinones for use as sonosensitizers
AU2004297235A1 (en) 2003-12-04 2005-06-23 Vertex Pharmaceuticals Incorporated Quinoxalines useful as inhibitors of protein kinases
WO2007016762A1 (en) * 2005-08-10 2007-02-15 Quest Pharmatech Inc. Perylenequinone derivatives and uses thereof
US8454991B2 (en) * 2006-07-24 2013-06-04 Quest Pharmatech Inc. Method and device for photodynamic therapy
CN102138640B (zh) * 2011-01-14 2012-12-05 江南大学 苝醌化合物在制备防治禽类病毒饲料中的应用
CN109456210B (zh) * 2017-09-06 2020-09-25 中国科学院理化技术研究所 一种竹红菌素迫位和2-位同时氨基取代的衍生物及其制备方法和应用
CN109453408A (zh) * 2018-11-16 2019-03-12 江南大学 抗菌创伤敷料及其制备方法
CA3135291A1 (en) * 2019-03-29 2020-10-08 The Brigham And Women's Hospital, Inc. Targeted synergistic cancer immunotherapy
CN115282133A (zh) * 2021-12-06 2022-11-04 温州医科大学 竹红菌乙素在制备抗结肠癌药物中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1015033A2 (en) * 1997-01-10 2000-07-05 AltaRex, Corp. Substituted perylenequinones for use in photodynamic therapy
GB9710049D0 (en) * 1997-05-19 1997-07-09 Nycomed Imaging As Method
DK1009413T3 (da) * 1997-09-05 2007-06-11 Univ California Anvendelse af immunstimulerende oligonukleotider til forebyggelse eller behandling af astma
EP1820514A3 (en) * 1998-06-15 2007-10-17 AltaRex Medical Corporation Therapeutic compositions that produce an immune response by altering the antigen
US20020022032A1 (en) * 1999-04-23 2002-02-21 Curry Patrick Mark Immuno-adjuvant PDT treatment of metastatic tumors
ATE290879T1 (de) * 1999-08-18 2005-04-15 Altarex Medical Corp Therapeutische antikörper gegen das muc-1 antigen und verfahren zu deren verwendung
EP1276501B9 (en) * 2000-04-25 2007-01-24 Immunex Corporation Method for treatment of tumors using photodynamic therapy
US6627664B2 (en) * 2001-01-30 2003-09-30 Altachem Pharma Ltd. Perylenequinones for use as sonosensitizers
US8034803B2 (en) * 2001-02-06 2011-10-11 Qlt Inc. Photodynamic therapy of occult age-related macular degeneration

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BIOCHIMICA ET BIOPHYSICA ACTA, MOLECULAR BASIS OF DISEASE, vol. 1537, no. 3, JPN4007021630, 29 November 2001 (2001-11-29), pages 222 - 232, ISSN: 0000896093 *
BIOCHIMICA ET BIOPHYSICA ACTA, MOLECULAR BASIS OF DISEASE, vol. 1537, no. 3, JPN6009016519, 29 November 2001 (2001-11-29), pages 222 - 232, ISSN: 0001297141 *
J PHOTOCHEM PHOTOBIOL B, vol. 44, no. 2, JPN4007021629, 10 July 1998 (1998-07-10), pages 151 - 158, ISSN: 0000896092 *
J PHOTOCHEM PHOTOBIOL B, vol. 44, no. 2, JPN6009016518, 10 July 1998 (1998-07-10), pages 151 - 158, ISSN: 0001297140 *

Also Published As

Publication number Publication date
EP1357944B1 (en) 2007-06-13
CA2436233C (en) 2010-10-05
ATE364398T1 (de) 2007-07-15
DE60220642D1 (de) 2007-07-26
CA2436233A1 (en) 2002-08-08
US20040110846A1 (en) 2004-06-10
DE60220642T2 (de) 2008-02-21
AU2002234809B2 (en) 2005-04-07
EP1357944A2 (en) 2003-11-05
WO2002060482A3 (en) 2003-02-13
WO2002060482A2 (en) 2002-08-08
CN1665535A (zh) 2005-09-07

Similar Documents

Publication Publication Date Title
Hou et al. Nanoparticle‐based photothermal and photodynamic immunotherapy for tumor treatment
Pizova et al. Photodynamic therapy for enhancing antitumour immunity.
JP4148328B2 (ja) 細胞サイトゾルへの化合物の移入
Pass Photodynamic therapy in oncology: mechanisms and clinical use
US20090192071A1 (en) Use of photodynamic therapy to enhance treatment with immuno-modulating agents
Duan et al. Immune modulator and low-temperature PTT-induced synergistic immunotherapy for cancer treatment
Qiang et al. Combination of photodynamic therapy and immunomodulation: current status and future trends
JPH0688902B2 (ja) 新規なテトラピロ−ル医薬用組成物
JP2023041779A (ja) 標的化併用療法
Jori Factors controlling the selectivity and efficiency of tumour damage in photodynamic therapy
JP2004529091A (ja) 免疫療法剤と共に使用するためのペリレンキノン
AU2002234809A1 (en) Perylenequinones for use with immunotherapy agents
Zhang et al. Photosensitizer IR700DX-6T-and IR700DX-mbc94-mediated photodynamic therapy markedly elicits anticancer immune responses during treatment of pancreatic cancer
Moor et al. Mechanisms of photodynamic therapy
CN1531442A (zh) 用作光敏剂和声敏剂的苝醌
EP1476190B1 (en) Amino-substituted hypocrellins for use as sonosensitizers
Kah et al. Overcoming resistant cancerous tumors through combined photodynamic and immunotherapy (photoimmunotherapy)
JP5548874B2 (ja) がん免疫抑制解除剤及びがん免疫治療用組成物
Korbelik et al. Exploitation of immune response‐eliciting properties of hypocrellin photosensitizer SL052‐based photodynamic therapy for eradication of malignant tumors
Castro et al. Targeted photodynamic immunotherapy
Moloudi et al. Understanding the Photodynamic Therapy Induced Bystander and Abscopal Effects: A Review. Antioxidants 2023, 12, 1434
Lobo Immunological Effects of Photodynamic Therapy
Hamblin et al. Systemic Effects
Shams Split-dose photodynamic therapy: Optimizing cures while preventing disseminated tumors
HK1065709A (en) Perylenequinones for use as photosensitizers and sonosensitizers

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040705

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040705

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070918

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090421